{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:31:26Z","timestamp":1783632686517,"version":"3.55.0"},"reference-count":39,"publisher":"Bioscientifica","issue":"3","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":261,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Healthcare claims data are increasingly used to investigate the epidemiology of benign thyroid diseases. Here, we estimate the prevalence of treated hyper- and hypo-thyroidism and assess the potential sociodemographic and geographic disparities in France in 2020, given the country\u2019s poor epidemiological knowledge of these conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used the French national healthcare data system, which covers nearly the entire population residing in France (over 67 million inhabitants in metropolitan and overseas departments). Prevalent cases were identified based on patients\u2019 long-term disease status, hospitalisation for hyper- and hypo-thyroidism and reimbursements for thyroid hormones, antithyroid drugs, iodine-131 and thyroid surgery. Thyroid-stimulating hormone, antithyroid antibodies and previous therapy for thyroid cancer and hyperthyroidism were considered to characterise the origin and surveillance of hypothyroidism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 2020, we identified 112,992 and 2,986,333 cases of treated hyper- and hypo-thyroidism, respectively, with an overall prevalence of 0.17 and 4.45 per 100 inhabitants. Marked differences were observed in terms of sex, age group and geographic area (department) for both conditions and deprivation level of the place of residence for hyperthyroidism only. The proportion of hypothyroidism following previous therapy for thyroid cancer or hyperthyroidism was less than 10%. Adequate monitoring (thyroid-stimulating hormone checked in the past year) occurred in 73.7% of hypothyroid subjects, with large variations across departments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides prevalence estimates of treated hyper- and hypo-thyroidism at the national and departmental levels in France and improves epidemiological knowledge of both conditions. It also supports using healthcare claims data for their epidemiological surveillance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/etj-25-0041","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:20:54Z","timestamp":1749212454000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 2020"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7674-7192","authenticated-orcid":true,"given":"Jo\u00ebl","family":"Coste","sequence":"first","affiliation":[{"name":"Department of Non-Communicable Diseases and Injuries, French Public Health Agency (Sant\u00e9 publique France) 1 , ,","place":["Saint-Maurice, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Mandereau-Bruno","sequence":"additional","affiliation":[{"name":"Data Science Division, French Public Health Agency (Sant\u00e9 publique France) 2 , ,","place":["Saint-Maurice, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bertagna","sequence":"additional","affiliation":[{"name":"Endocrinologie, Universit\u00e9 Paris-Cit\u00e9 3 , ,","place":["Paris, France"]},{"name":"Acad\u00e9mie Nationale de M\u00e9decine 4 , ,","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"W\u00e9meau","sequence":"additional","affiliation":[{"name":"Acad\u00e9mie Nationale de M\u00e9decine 4 , ,","place":["Paris, France"]},{"name":"Endocrinologie, Universit\u00e9 de Lille 5 , ,","place":["Lille, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"2026070712540931500_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2458-9-132","article-title":"Trends in thyroid hormone prescribing and consumption in the UK","volume":"9","author":"Mitchell","year":"2009","journal-title":"BMC Public Health"},{"key":"2026070712540931500_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026070712540931500_bib3","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1210\/jc.2003-032089","article-title":"The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population","volume":"89","author":"Flynn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712540931500_bib4","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(16)00580-8","article-title":"Achieving universal health coverage in France: policy reforms and the challenge of inequalities","volume":"387","author":"Nay","year":"2016","journal-title":"Lancet"},{"key":"2026070712540931500_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0003-4266(04)95956-2","article-title":"Statut thyro\u00efdien et fr\u00e9quences des dysthyro\u00efdies chez les adultes inclus dans l'\u00e9tude SU.VI.MAX en 1994-1995 [Thyroid hormone levels and thyroid dysfunction of French adults participating in the SU.VI.MAX study]","volume":"65","author":"Valeix","year":"2004","journal-title":"Ann Endocrinol"},{"key":"2026070712540931500_bib6","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1210\/jc.2018-00273","article-title":"Epidemiology of childhood hyperthyroidism in France: a nationwide population-based study","volume":"103","author":"Simon","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712540931500_bib7","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2026070712540931500_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2458-9-33","article-title":"Ecological association between a deprivation index and mortality in France over the period 1997\u20132001: variations with spatial scale, degree of urbanicity, age, gender and cause of death","volume":"9","author":"Rey","year":"2009","journal-title":"BMC Public Health"},{"key":"2026070712540931500_bib9","article-title":"Estimation of the prevalence of thyroid dysfunction in Catalonia through two different registries: pharmaceutical dispensing and diagnostic registration","volume":"4","author":"Torrej\u00f3n","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"2026070712540931500_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3803\/EnM.2023.1684","article-title":"Prevalence, treatment status, and comorbidities of hyperthyroidism in Korea from 2003 to 2018: a nationwide population study","volume":"38","author":"Ahn","year":"2023","journal-title":"Endocrinol Metab"},{"key":"2026070712540931500_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-020-02222-7","article-title":"Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont region, Italy","volume":"69","author":"Caputo","year":"2020","journal-title":"Endocrine"},{"key":"2026070712540931500_bib12","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/jc.2013-2409","article-title":"The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis","volume":"99","author":"Garmendia Madariaga","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070712540931500_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ando.2018.09.002","article-title":"Graves' disease: introduction, epidemiology, endogenous and environmental pathogenic factors","volume":"79","author":"W\u00e9meau","year":"2018","journal-title":"Ann Endocrinol"},{"key":"2026070712540931500_bib14","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"key":"2026070712540931500_bib15","volume-title":"Oxford Textbook of Geriatric Medicine","author":"W\u00e9meau","edition":"4th edition"},{"key":"2026070712540931500_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s42000-023-00435-9","article-title":"Prevalence of thyroid dysfunction and its relationship to income level and employment status: a nationwide population-based study in Spain","volume":"22","author":"D\u00edez","year":"2023","journal-title":"Hormones"},{"key":"2026070712540931500_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijcard.2014.03.012","article-title":"Frequency of cardiovascular diseases and risk factors treated in France according to social deprivation and residence in an overseas territory","volume":"173","author":"Tuppin","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026070712540931500_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00415-023-11953-2","article-title":"Prevalence, demographic and spatial distribution of treated epilepsy in France in 2020: a study based on the French national health data system","volume":"271","author":"Coste","year":"2024","journal-title":"J Neurol"},{"key":"2026070712540931500_bib19","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(99)01115-0","article-title":"Iodine deficiency in France","volume":"353","author":"Valeix","year":"1999","journal-title":"Lancet"},{"key":"2026070712540931500_bib20","article-title":"\u00c9tude nationale nutrition sant\u00e9 (ENNS, 2006). Situation nutritionnelle en France en 2006 selon les indicateurs d\u2019objectifs et les rep\u00e8res du Programme national nutrition sant\u00e9 (PNNS), InVS, Universit\u00e9 Paris 13, CNAM","author":"Unit\u00e9 de surveillance et d\u2019\u00e9pid\u00e9miologie nutritionnelle (Usen)","year":"2007"},{"key":"2026070712540931500_bib21","first-page":"103","article-title":"Iodine deficiency, still a global problem?","volume":"43","author":"Biban","year":"2017","journal-title":"Curr Health Sci J"},{"key":"2026070712540931500_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12902-023-01450-y","article-title":"What is the impact of stress on the onset and anti-thyroid drug therapy in patients with graves' disease: a systematic review and meta-analysis","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"2026070712540931500_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/eje.0.1460153","article-title":"Smoking and thyroid disorders--a meta-analysis","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2026070712540931500_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1749-6632.1999.tb08111.x","article-title":"Socioeconomic status and chronic stress. Does stress account for SES effects on health?","volume":"896","author":"Baum","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"2026070712540931500_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.2011.06202.x","article-title":"Socioeconomic status and smoking: a review","volume":"1248","author":"Hiscock","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"2026070712540931500_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/thy.1998.8.37","article-title":"The significant increase in incidence of Graves' disease in eastern Serbia during the civil war in the former Yugoslavia (1992 to 1995)","volume":"8","author":"Paunkovic","year":"1998","journal-title":"Thyroid"},{"key":"2026070712540931500_bib27","first-page":"e1","article-title":"Prevalencia de hipotiroidismo en Andaluc\u00eda seg\u00fan el consumo de hormona tiroidea en 2014 [Prevalence of Hypothyroidism in Andalusia, Spain, Determined by Thyroid Hormone Comsumption]","volume":"90","author":"Escribano-Serrano","year":"2016","journal-title":"Rev Esp Salud Publica"},{"key":"2026070712540931500_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00228-010-0884-4","article-title":"Prevalence of hypothyroidism in Finland--a nationwide prescription study","volume":"67","author":"Virta","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"2026070712540931500_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3803\/EnM.2015.30.3.288","article-title":"Incidence and prevalence of overt hypothyroidism and causative diseases in Korea as determined using claims data provided by the health insurance review and assessment service","volume":"30","author":"Seo","year":"2015","journal-title":"Endocrinol Metab"},{"key":"2026070712540931500_bib30","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamainternmed.2015.0324","article-title":"Reducing inappropriate polypharmacy: the process of deprescribing","volume":"175","author":"Scott","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026070712540931500_bib31","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/jamainternmed.2021.2686","article-title":"Levothyroxine use in the United States, 2008\u20132018","volume":"181","author":"Brito","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2026070712540931500_bib32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026070712540931500_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2021.102051","article-title":"Temporal and geographical variations of thyroid cancer incidence and mortality in France during 1986\u20132015: the impact of overdiagnosis","volume":"75","author":"Li","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"2026070712540931500_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/CEJ.0000000000000732","article-title":"Evolution of socioeconomic inequalities in cancer incidence between 2006 and 2016 in France: a population-based study","volume":"31","author":"Derette","year":"2022","journal-title":"Eur J Cancer Prev"},{"key":"2026070712540931500_bib35","volume-title":"Epidemiologic Methods for Health Policy","author":"Spasoff","year":"1999"},{"key":"2026070712540931500_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.22.1.213","article-title":"Administrative data for public health surveillance and planning","volume":"22","author":"Virnig","year":"2001","journal-title":"Annu Rev Public Health"},{"key":"2026070712540931500_bib37","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/jech-2013-202744","article-title":"Use of administrative medical databases in population-based research","volume":"68","author":"Gavrielov-Yusim","year":"2014","journal-title":"J Epidemiol Community Health"},{"key":"2026070712540931500_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12020-019-02045-1","article-title":"Thyroid hormone misuse and abuse","volume":"66","author":"Bernet","year":"2019","journal-title":"Endocrine"},{"key":"2026070712540931500_bib39","doi-asserted-by":"crossref","first-page":"k714","DOI":"10.1136\/bmj.k714","article-title":"Risks of reformulation: French patients complain after Merck modifies levothyroxine pills","volume":"360","author":"Casassus","year":"2018","journal-title":"BMJ"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/etj.bioscientifica.com\/view\/journals\/etj\/14\/3\/ETJ-25-0041.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/etj.bioscientifica.com\/downloadpdf\/journals\/etj\/14\/3\/ETJ-25-0041.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0041\/33085\/etj-25-0041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/doi\/10.1530\/ETJ-25-0041\/33085\/etj-25-0041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:22:16Z","timestamp":1783444936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/14\/3\/e250041\/4460\/Prevalence-of-treated-hyper-and-hypo-thyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/etj-25-0041","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"e250041"}}